Journal of Antimicrobial Chemotherapy, Vol 41, 85-91, Copyright © 1998 by The British Society for Antimicrobial Chemotherapy
E Sprinz, R Mallman, S Barcellos, S Silbert, G Schestatsky and D Bem David
In immunocompromised patients, cryptosporidial diarrhoea is a debilitating
and potentially life-threatening infection for which no effective specific
therapy exists. In an uncontrolled study of 24 AIDS patients with diarrhoea
exclusively due to Cryptosporidium spp., treatment with roxithromycin, 300
mg bd for 4 weeks, produced symptomatic improvement of diarrhoea in 79% of
cases, with 50% of patients achieving complete response. The response rate
was 100% in a subgroup of five patients with no previous or concomitant
opportunistic infections. In complete responders, improvement was rapid,
occurring within 3-5 days, and the duration of response was at least 6
months. Response did not appear to be correlated with the degree of
immunodeficiency. The most limiting adverse effects were abdominal pain
(two patients), elevated hepatic enzymes (two patients) and abdominal pain
with elevated hepatic enzymes (one patient). Minor symptoms, such as
gastrointestinal upset, occurred in nine patients. We conclude that
roxithromycin is relatively well tolerated and effective against
cryptosporidial diarrhoea in AIDS patients. Further studies to optimize
dosing regimens are required.
ORIGINAL ARTICLES
AIDS-related cryptosporidial diarrhoea: an open study with roxithromycin
Department of Internal Medicine, Hospital de Clinicas de Porto Alegre, Universidade Federal Do Rio Grande do Sul, Brazil.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. F. Berg, B. Maraha, A. van der Zee, S. K. Gielis, P. J. M. Roholl, G.-J. Scheffer, M. F. Peeters, and J. A. J. W. Kluytmans Effect of Clarithromycin Treatment on Chlamydia pneumoniae in Vascular Tissue of Patients with Coronary Artery Disease: a Randomized, Double-Blind, Placebo-Controlled Trial J. Clin. Microbiol., March 1, 2005; 43(3): 1325 - 1329. [Abstract] [Full Text] [PDF] |
||||
